[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial on the efficacy, safety, and pharmacokinetic characteristics of oxymetazoline hydrochloride eye drops in the treatment of acquired ptosis in Chinese adults
评价盐酸羟甲唑啉滴眼液在中国成人获得性上睑下垂患者中的有效性、安全性和药代动力学(PK)特征。
[Translation] To evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of oxymetazoline hydrochloride eye drops in Chinese adult patients with acquired ptosis.